Jianzhong Zhang

30PUBLICATIONS
82CO-AUTHORS
Pharmaceutical delivery technologiesPharmacogenomicsAdolescent healthGene and molecular therapyAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|May 03, 2026
Rapid Onset of Action and Quality-of-Life Improvements in Chinese Patients with Plaque Psoriasis Treated with Calcipotriol plus Betamethasone Dipropionate Aerosol Foam in a Randomized Phase 3 Trial.

|Mar 23, 2026
HS-20137 for Chinese Moderate-to-Severe Psoriasis: A Randomized, Double-Blinded, Phase 2 Study.

Lin Cai, Xiaohua Wang, Litao Zhang

|Feb 16, 2026
Efficacy and safety of stapokibart in adolescents with moderate-to-severe atopic dermatitis: a multicentre randomized double-blind placebo-controlled phase III trial.

Cheng Zhou, Yan Zhao, Guannan Zhu

|Feb 12, 2026
Bimekizumab efficacy and safety in Chinese patients with psoriasis in the BE SHINING Phase 3 study.

Lin Cai, Xiao-Yong Man, Jinyan Wang

|Nov 22, 2025
Efficacy and Safety of Anti-IL-4Rα Stapokibart in Elderly Patients With Moderate-To-Severe Atopic Dermatitis.

Yan Zhao, Litao Zhang, Liming Wu

|Nov 19, 2025
Efficacy and Safety of Stapokibart in Adults With Moderate-to-Severe Atopic Dermatitis With and Without Type 2 Comorbidities: A Post Hoc Analysis of a Phase 3 Trial.

Yan Zhao, Litao Zhang, Liming Wu

Pageof 5

Frequent Collaborators

4 joint publications

Xiaoyong Man

4 joint publications

Xinghua Gao

3 joint publications

Yu-Qing Hu

3 joint publications

Yan Zhao